openPR Logo
Press release

Endobronchial Ultrasound Biopsy Market Growing at 5.84% CAGR, Expected to Reach USD 1.25 Billion by 2033 - Strategic Revenue Insights

11-28-2025 05:15 PM CET | Health & Medicine

Press release from: Strategic Revenue Insights Inc.

Endobronchial Ultrasound Biopsy Market Growing at 5.84% CAGR,

London, UK - November 2025 | Strategic Revenue Insights Inc. - The global Endobronchial Ultrasound Biopsy (EBUS Biopsy) market continues to gain considerable traction, with our latest research showing the market growing from USD 751.60 million in 2024 to a projected USD 1.25 billion by 2033.

This growth translates into a compound annual growth rate (CAGR) of 5.84 %, as rising disease burden and improvements in diagnostic technology push broader adoption of EBUS procedures.

The progression from USD 751.60 million in 2024 to USD 1.25 billion by 2033 marks an increase of nearly USD 500 million over the forecast period a result of increasing reliance on minimally invasive diagnostic procedures for lung and thoracic conditions. The market showed earlier growth between 2018 and 2024, as clinicians moved away from more invasive surgical diagnostics toward image-guided biopsy techniques that offer lower risk and faster recovery times.

A comprehensive assessment of this rapidly evolving market can be accessed through Strategic Revenue Insights at the link below, focused on Endobronchial Ultrasound Biopsy:

https://www.strategicrevenueinsights.com/industry/endobronchial-ultrasound-biopsy-market

Rising prevalence of lung cancer, chronic respiratory diseases, and growing awareness about early detection of thoracic conditions form the core demand drivers. As healthcare providers and patients increasingly favor procedures that reduce invasiveness and improve diagnostic accuracy, demand for EBUS systems has grown. Concurrently, ongoing technological advances including improvements in ultrasound imaging resolution, biopsy needle design, and real-time navigation have enhanced the safety, reliability, and usability of EBUS biopsy procedures, further encouraging adoption.

Regional market dynamics show clear variation. Mature healthcare systems in North America continue to dominate the market share, driven by established hospital infrastructure, high incidence of respiratory disorders, and greater capacity for diagnostic investment. At the same time, the Asia-Pacific region and other emerging economies are showing the fastest growth rates, supported by rising healthcare expenditure, expanding diagnostic infrastructure, and growing demand for minimally invasive procedures in both urban and rural settings.

Browse the associated report:

https://www.strategicrevenueinsights.com/ja/industry/endobronchial-ultrasound-biopsy-market

https://www.strategicrevenueinsights.com/kr/industry/endobronchial-ultrasound-biopsy-market

https://www.strategicrevenueinsights.com/da/industry/endobronchial-ultrasound-biopsy-market

The competitive landscape in the EBUS biopsy market features major global medical-device companies and specialized diagnostic-equipment manufacturers. While the report by Strategic Revenue Insights highlights firms like Siemens Healthiness as well positioned due to their focus on advanced diagnostic solutions, the broader space also includes other well-known players offering scopes, needles, imaging processing systems and associated consumables.

Segmentation analysis reveals a clear breakdown by component, application, and end user. By component, the market includes EBUS scopes, biopsy needles, imaging/ultrasound processors and related accessories with scopes typically holding a significant share because of their role in real-time navigation and tissue sampling.

By procedure type, EBUS-guided transbronchial needle aspiration remains the most common, serving a majority of diagnostic biopsy needs for lung cancer and mediastinal lymph node evaluation. End users predominantly include hospitals, diagnostic centers, and specialty clinics though ambulatory surgical centers and outpatient diagnostic facilities are gaining traction as EBUS procedures become more accessible and demand increases.

Looking ahead toward 2033 and beyond, the EBUS biopsy market appears set for steady growth as global healthcare systems continue to emphasize early diagnosis, minimally invasive procedures, and efficient patient throughput. Upgrades in ultrasound imaging technology, broader availability of equipment in emerging markets, and increased training of skilled professionals are likely to drive further adoption.

Particularly in regions with rising lung disease burden, expansion of diagnostic centers, and growing healthcare budgets including parts of Asia-Pacific, Latin America, and the Middle East the opportunity for market expansion remains substantial. Continuous innovation in device design (lighter scopes, more precise needles, integrated imaging & analytics) and favorable healthcare policies supporting early detection will likely push the market past the USD 1.25 billion mark, potentially even higher as procedure costs decrease and accessibility improves.

Related Reports:

https://www.strategicrevenueinsights.com/industry/osteoarthritis-topical-diclofenac-market

Media Contact

Company Name: Strategic Revenue Insights Inc.

Contact Person: Ashwani

Email: sales@strategicrevenueinsights.com

Phone: +44 7877 403352

Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL

City: London

Country: United Kingdom

Website: www.strategicrevenueinsights.com

Website: www.strategicpackaginginsights.com

About Strategic Revenue Insights Inc.
Strategic Revenue Insights Inc., a subsidiary of SRI Consulting Group Ltd, empowers organizations worldwide with data driven market intelligence. Headquartered in London, United Kingdom, the firm delivers syndicated research reports, tailored consulting solutions, and actionable insights that equip clients to make confident, future focused strategic decisions. Its team of seasoned analysts continuously tracks markets, identifies emerging trends, and uncovers growth opportunities to support long-term client success. As part of SRI Consulting Group Ltd, Strategic Revenue Insights Inc. is committed to accuracy, clarity, and practical relevance, helping businesses optimize strategies and accelerate revenue growth.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endobronchial Ultrasound Biopsy Market Growing at 5.84% CAGR, Expected to Reach USD 1.25 Billion by 2033 - Strategic Revenue Insights here

News-ID: 4293366 • Views:

More Releases from Strategic Revenue Insights Inc.

Bottom Mounted Homogenizer Market Valued at $836.0 Million in 2024, Projected to Reach $1,149.3 Million by 2033 at a 3.6% CAGR - Strategic Revenue Insights (SRI)
Bottom Mounted Homogenizer Market Valued at $836.0 Million in 2024, Projected to …
The global Bottom Mounted Homogenizer Market is gaining strong momentum as industries increasingly demand high-efficiency mixing, emulsification, and particle size reduction solutions that deliver consistency, hygiene, and operational reliability. Bottom mounted homogenizers, installed directly at the base of processing vessels, enable uniform shear distribution and complete batch utilization, making them indispensable in sectors such as pharmaceuticals, biotechnology, food and beverages, cosmetics, and specialty chemicals. As manufacturers across these industries strive
Recombinant Collagen Market Valued at $1.2 Billion in 2024, Projected to Reach $3.8 Billion by 2033 at a 13.7% CAGR - Strategic Revenue Insights (SRI)
Recombinant Collagen Market Valued at $1.2 Billion in 2024, Projected to Reach $ …
The global Recombinant Collagen Market is emerging as a pivotal segment within the broader biomaterials and life sciences landscape, driven by the convergence of biotechnology, regenerative medicine, and clean label consumer demand. Recombinant collagen, produced through controlled microbial or cellular expression systems, offers a highly consistent, animal free, and scalable alternative to traditional collagen sources. Its growing adoption across pharmaceuticals, tissue engineering, cosmetics, food supplements, and medical devices reflects a
Pharmaceutical Autoclave Machine Market Valued at $2.200 million in 2024, Projected to Reach $2.904 million by 2033 at a 4.7% CAGR - Strategic Revenue Insights (SRI)
Pharmaceutical Autoclave Machine Market Valued at $2.200 million in 2024, Projec …
The global Pharmaceutical Autoclave Machine Market is witnessing sustained expansion as pharmaceutical manufacturers, biotechnology companies, and contract manufacturing organizations intensify their focus on sterility assurance, regulatory compliance, and contamination control. Pharmaceutical autoclave machines play a foundational role in sterilizing instruments, materials, glassware, media, and pharmaceutical products, ensuring patient safety and product integrity across the drug development and manufacturing lifecycle. In an era marked by rising biologics production, vaccine manufacturing, and
Self-Propelled Transport Barge Market Valued at $6.70 Billion in 2024, Projected to Reach $8.4 Billion by 2033 at a 3.7% CAGR - Strategic Revenue Insights (SRI)
Self-Propelled Transport Barge Market Valued at $6.70 Billion in 2024, Projected …
The global Self-Propelled Transport Barge Market is emerging as a strategic component of modern waterborne logistics, driven by the need for cost efficient, flexible, and environmentally responsible cargo transportation. Self-propelled transport barges are engineered with onboard propulsion systems, eliminating dependency on tugboats and enabling greater operational autonomy across inland waterways, coastal routes, and industrial ports. These vessels play a critical role in transporting heavy equipment, bulk commodities, construction materials, and

All 5 Releases


More Releases for EBUS

Endobronchial Ultrasound (EBUS) Needles) Market Size, Sales, Average Price and T …
Endobronchial Ultrasound (EBUS) Needles) Market Size is estimated to be $325million in 2024 and is expected to grow at an average yearly rate of around 4.3% during the timeframe (2025-2032). Monitor Country-wise Endobronchial Ultrasound (EBUS) Needles) Sales and Demand with Our Comprehensive Endobronchial Ultrasound (EBUS) Needles) Sales Database Gain in-depth insights into the Endobronchial Ultrasound (EBUS) Needles) Sales landscape across 20+ countries with our specialized Endobronchial Ultrasound (EBUS) Needles) Sales
eBus Charging System Market Growth, Opportunities, Industry Applications, Analys …
Los Angeles, United State: The global eBus Charging System market is comprehensive and accurately presented in the report with the help of detailed market information and data, critical findings, error-free statistics, and reliable forecasts. The report digs deep into important aspects of the global eBus Charging System market, including competition, segmentation, regional expansion, and market dynamics. Each leading trend of the global eBus Charging System market is carefully studied and
Profitable Strategic Report Electric Drive Buses Market With Included Analysis o …
Electric Drive Buses Market report 2022 gives a brief well-informed report so that the purchaser or readers will get help from it for investment in Electric Drive Buses Industry. The report is properly deliberate and gathered by Market professionals and will shed light on the key information that requires from the consumers like market share, size, top key players, and other important data. The Electric Drive Buses Market is expected
Endobronchial Ultrasound (EBUS) Biopsy Needle Market Demands, Growth Rate, Trend …
The Endobronchial Ultrasound (EBUS) Biopsy Needle Market research report covers market production, definition, and application. It is essentially divided into a few key locales, import/ export, income, and developments in the Endobronchial Ultrasound (EBUS) Biopsy Needle Market. The Endobronchial Ultrasound (EBUS) Biopsy Needle Market research report provides features of the vital market fragments and market players. In addition, it covers market patterns with market share, size, and development by
Endobronchial Ultrasound (EBUS) Devices Market Size, Increasing Trends, Future S …
Precision Business Insights published a research report on “Global Endobronchial Ultrasound (EBUS) Devices Market by Type (Radial EBUS, Linear EBUS, Sequential Transbronchial Needle Aspiration (TBNA), CP-EBUS, Real-time Transbronchial Needle Aspiration (TBNA)), Indication (Lung Cancer, Endobrocnchial Lesions, Mediastinal and Hilar lymphadenopathy, Lymphoma, Others), End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Geography- Global/Region/Country Forecast to 2027”. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65
Electric Buses Market Share 2017-2022: Ursus, Easy Go Electric, Temsa, GreenPowe …
Electric Buses Market Research Report A market study ” Global Electric Buses Market ” examines the performance of the Electric Buses market Size 2017. It encloses an in-depth Research of the Electric Buses market state and the competitive landscape globally. This report analyzes the potential of Electric Buses market in the present and the future prospects from various angles in detail. The Global Electric Buses Market 2017 report includes Electric Buses